Prophylaxis of Venous Thromboembolism After Bariatric Surgery

• Status: Unknown status
• Trial end date: 2015-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is a prospective evaluation of the relationship between lean body weight and anti-Xa activity and 5700 International Units (IU) nadroparin 4 hours after subcutaneous administration in morbidly obese patients after bariatric surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rijnstate Hospital
• Treatments: Dalteparin; Heparin, Low-Molecular-Weight; Nadroparin

Criteria

Inclusion Criteria:

• Approval for Roux-en-Y gastric bypass

• Total body weight > 140 kg

Exclusion Criteria:

• Renal impairment (GFR < 30ml/min and/ or serum creatinin > 150 micromol/ml)

• Coagulation disorders

• Use of vitamin K antagonists (such as acenocoumarol) pregnancy